Clinical genetic testing in Parkinson's disease should become part of routine patient care.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 39087915.
- Also identified by DOI 10.1093/brain/awae181 and PMC identifier 11292891.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This scientific commentary refers to ‘Relevance of genetic testing in the gene-targeted trial era: the Rostock Parkinson’s Disease Study’ by Westenberger <i>et al.</i> (https://doi.org/10.1093/brain/awae188) and ‘Parkinson’s disease variant detection and disclosure: PD GENEration, a North American study’ by Cook <i>et al</i>. (https://doi.org/10.1093/brain/awae142).
Medical subject headings
- Parkinson Disease
- Genetic Testing